基于“态靶因果”探析慢性胰腺炎“炎癌转化”的病机演变与论治策略

戴云飞; 尚东; 项红; 关溪; 赵亮; 白长川

doi:10.3969/j.issn.1006-2157.2024.10.005

您当前的位置：

首页 >

文章列表页 >

基于“态靶因果”探析慢性胰腺炎“炎癌转化”的病机演变与论治策略

“中医药防治‘炎癌转化’”专题 | 更新时间：2024-10-29

- 基于“态靶因果”探析慢性胰腺炎“炎癌转化”的病机演变与论治策略
- Analysis of pathogenesis evolution and therapeutic strategies for " inflammation-cancer transformation" in chronic pancreatitis based on " state-target-cause-result"
- 北京中医药大学学报 2024年47卷第10期页码：1360-1366
- 作者机构：
  
  1.大连医科大学附属第一医院　大连　116011
  2.大连医科大学中西医结合研究院/学院
  3.辽宁省胆胰疾病中西医结合治疗中心
- 作者简介：
  
  戴云飞，男，在读硕士生
  #赵亮，男，博士，副主任医师，硕士生导师，主要研究方向：中西医结合外科，E-mail: zhaoliangeagle@163.com
- 基金信息：
  
  国家中医药管理局第七批全国老中医药专家学术经验继承项目(国中医药办人教函〔2021〕272号);兴辽英才计划(XLYC2212013)
- DOI：10.3969/j.issn.1006-2157.2024.10.005
  中图分类号： R256.3
- 纸质出版日期：2024-10-30，
  
  网络出版日期：2024-08-21，
  
  收稿日期：2024-04-29，
- 稿件说明：
移动端阅览
戴云飞, 尚东, 项红, 等. 基于“态靶因果”探析慢性胰腺炎“炎癌转化”的病机演变与论治策略[J]. 北京中医药大学学报, 2024,47(10):1360-1366.

DAI Yunfei, SHANG Dong, XIANG Hong, et al. Analysis of pathogenesis evolution and therapeutic strategies for " inflammation-cancer transformation" in chronic pancreatitis based on " state-target-cause-result"[J]. Journal of Beijing University of Traditional Chinese Medicine, 2024,47(10):1360-1366.
戴云飞, 尚东, 项红, 等. 基于“态靶因果”探析慢性胰腺炎“炎癌转化”的病机演变与论治策略[J]. 北京中医药大学学报, 2024,47(10):1360-1366. DOI： 10.3969/j.issn.1006-2157.2024.10.005.

DAI Yunfei, SHANG Dong, XIANG Hong, et al. Analysis of pathogenesis evolution and therapeutic strategies for " inflammation-cancer transformation" in chronic pancreatitis based on " state-target-cause-result"[J]. Journal of Beijing University of Traditional Chinese Medicine, 2024,47(10):1360-1366. DOI： 10.3969/j.issn.1006-2157.2024.10.005.

摘要

“态靶因果”是在中医整体观基础上结合西医学研究进展提出的一种宏观与微观辨证相结合的临床辨治新思维。慢性胰腺炎“炎癌转化”是胰腺与多种病理因素、多个对象相互影响的复杂病理过程，涉及多种稳态的失衡。将慢性胰腺炎“炎癌转化”这一微观过程作为“靶”，将在慢性炎症状态下可能诱导其发生的各类因素作为“态”。将慢性胰腺炎“炎癌转化”概括为阴阳失衡，气运失调，湿热瘀痰浊内生而滞，胶结不解，因滞而虚，虚实夹杂，癌毒内生的过程。提出从“态”这一更为宏观的角度阐述慢性胰腺炎“炎癌转化”的病机演变与干预策略，即通过减少“态”的失衡对“靶”的影响，建立起胰腺－免疫－微生物共平衡状态的思维，以期为中医药及西医学对于慢性胰腺炎“炎癌转化”机制与药物研发的探索拓宽思路。

Abstract

" State-target-cause-result" is a new clinical theory combining macroscopic and microscopic syndrome differentiation based on the holistic view of traditional Chinese medicine combined with Western medical research. The " inflammation-cancer transformation" of chronic pancreatitis is a complex pathological process that is associated with the interaction between the pancreas and various pathological factors and multiple objects

involving the imbalance of multiple homeostasis. The microscopic process of " inflammation-cancer transformation" in chronic pancreatitis is the " target

" whereas various factors that could induce its occurrence under chronic inflammatory conditions are the " state." The " inflammation-cancer transformation" of chronic pancreatitis is summarized as yin and yang imbalance

qi movement disorder

endogenous dampness

heat

blood stasis

and turbid phlegm stagnation

unresolved congestion resulting in deficiency caused by stagnation

intermingled deficiency and excess

and internal cancer toxin generation. This paper elucidates the pathogenesis and intervention strategies of the " inflammation-cancer transformation" of chronic pancreatitis from a macro perspective of " state

" focusing on reducing the impact of " state" imbalance on the " target" to establish a balanced pancreas-immune-microbiota state. The aim is to broaden the theory for exploring the mechanism and drug development related to chronic pancreatitis " inflammation-cancer transformation" in both traditional Chinese and Western medicine.

关键词

态靶因果慢性胰腺炎炎癌转化胰腺癌治未病

Keywords

state-target-cause-resultchronic pancreatitisinflammation-cancer transformationpancreatic cancerpreventive treatment of disease

references

SIEGEL R, MILLER K, WAGLE NS, et al. Cancer statistics, 2023[J]. CA A Cancer J Clin, 2023, 73: 17-48.

WANG S, ZHENG Y, YANG F, et al. The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives[J]. Signal Transduct Target Ther, 2021, 6(1): 249.

CAI J, CHEN H, LU M, et al. Advances in the epidemiology of pancreatic cancer: trends, risk factors, screening, and prognosis[J]. Cancer Lett, 2021, 520: 1-11.

KIRKEGÅRD J, MORTENSEN FV, CRONIN-FENTON D. Chronic pancreatitis and pancreatic cancer risk: a systematic review and meta-analysis[J]. Am J Gastroenterol, 2017, 112(9): 1366-1372.

蔡少青，王璇，尚明英，等．中药“显效理论”或有助于阐释并弘扬中药特色优势[J].中国中药杂志，2015，40(17)：3435-3443.

仝小林，何莉莎，赵林华. 论“态靶因果”中医临床辨治方略[J]. 中医杂志，2015, 56(17): 1441-1444.

张莉莉，薛崇祥，周凌，等. 由靶及态之现代中西医结合医学模式探析[J]. 中医杂志，2023, 64(22): 2269-2274.

何莉莎，宋攀，赵林华，等．态靶辨证——中医从宏观走向精准的历史选择[J].辽宁中医杂志，2020，47(1)：1-4.

逄冰，刘文科，林轶群，等. 论“态靶因果”辨治方略在2型糖尿病中的应用[J]. 中华中医药杂志，2017, 32(7): 2864-2866.

李烁，李敏，安心怡，等. 仝小林“态靶结合”辨治糖尿病视网膜病变经验[J]. 辽宁中医杂志，2021, 48(11): 24-26.

杨映映，李青伟，魏秀秀，等. “四型分类”辨治高血压病[J]. 中医杂志，2019, 60(7): 562-567.

程海波，王俊壹，李柳，等. 恶性肿瘤态靶辨治体系的初步构建[J]. 中医杂志，2023, 64(13): 1317-1321.

周凌峰，郑晓，孙阳，等. 基于态靶理论探讨早期膝骨关节炎的辨治思路[J]. 中医正骨，2024, 36(1): 63-65.

赵亮，尚东，马跃海，等. 基于“胰脾一体”观点探讨胰腺疾病的中医辨治[J]. 中医杂志，2023, 64(16): 1646-1650.

张立志，许能贵，杨小林，等. 基于“脾气散精”理论探讨从脾论治胰岛素抵抗[J]. 中国中医基础医学杂志，2022, 28(6): 875-877.

张传龙，李奕，姜晓晨，等. 从“脾为之卫”探讨延缓胰腺癌演进的治脾调卫机理与策略[J]. 北京中医药大学学报，2023, 46(3): 326-330.

ZHOU B, XU JW, CHENG YG, et al. Early detection of pancreatic cancer: Where are we now and where are we going[J]. Int J Cancer, 141(2)：231-241.

MILLER FH, LOPES VENDRAMI C, HAMMOND NA, et al. Pancreatic cancer and its mimics[J]. Radiographics, 2023, 43(11): e230054.

STOFFEL EM, BRAND RE, GOGGINS M. Pancreatic cancer: changing epidemiology and new approaches to risk assessment, early detection, and prevention[J]. Gastroenterology, 2023, 164(5): 752-765.

CHRISTENSON ES, JAFFEE E, AZAD NS. Current and emerging therapies for patients with advanced pancreatic ductal adenocarcinoma: a bright future[J]. Lancet Oncol, 2020, 21(3): e135-e145.

ALONSO-CURBELO D, HO YJ, BURDZIAK C, et al. A gene-environment-induced epigenetic program initiates tumorigenesis[J]. Nature, 2021, 590(7847): 642-648.

BÖTTCHER A, BÜTTNER M, TRITSCHLER S, et al. Non-canonical Wnt/PCP signalling regulates intestinal stem cell lineage priming towards enteroendocrine and Paneth cell fates[J]. Nat Cell Biol, 2021, 23(1): 23-31.

KOPP JL, GROMPE M, SANDER M. Stem cells versus plasticity in liver and pancreas regeneration[J]. Nat Cell Biol, 2016, 18(3): 238-245.

BURDZIAK C, ALONSO-CURBELO D, WALLE T, et al. Epigenetic plasticity cooperates with cell-cell interactions to direct pancreatic tumorigenesis[J]. Science, 2023, 380(6645): eadd5327.

DEL POGGETTO E, HO IL, BALESTRIERI C, et al. Epithelial memory of inflammation limits tissue damage while promoting pancreatic tumorigenesis[J]. Science, 2021, 373(6561): eabj0486.

韦天夫，周琪，胡凤林，等. 慢性胰腺炎炎癌转化中医理论浅析[J]. 时珍国医国药，2020, 31(5): 1192-1194.

孟小莎，孙铜林，刘华. 基于“阳化气，阴成形”理论初探胰腺癌的中医论治[J]. 中国民族民间医药，2021, 30(14): 89-91.

李奕，张曦元，庞博，等. 胰腺癌从“调气解毒”立论的中医药治疗策略与实践[J]. 世界中医药，2022, 17(11): 1502-1505.

李越，吕红艳，梁天宇，等．基于络病理论探讨胰腺癌炎癌转化的防治[J].现代中医临床，2024，31(2)：69-72.

邵沁，吴辰恒，凌江红. 基于络病学说探讨慢性胰腺炎相关病机及治法[J]. 中国中医基础医学杂志，2023, 29(5): 823-825.

陈萌，凌江红，魏珏，等. 基于阴火理论探讨慢性胰腺炎“炎-癌转化”与防治策略[J]. 上海中医药杂志，2023, 57(6): 12-15.

金香兰. “治病必求于本”探微[J]. 中国中医基础医学杂志，2008, 14(1): 17-18.

BEYER G, HABTEZION A, WERNER J, et al. Chronic pancreatitis[J]. Lancet, 2020, 396(10249): 499-512.

MEDZHITOV R. The spectrum of inflammatory responses[J]. Science, 2021, 374(6571): 1070-1075.

ZHAO HK, WU L, YAN GF, et al. Inflammation and tumor progression: signaling pathways and targeted intervention[J]. Signal Transduct Target Ther, 2021, 6(1): 263.

SENDER R, FUCHS S, MILO R. Revised estimates for the number of human and bacteria cells in the body[J]. PLoS Biol, 2016, 14(8): e1002533.

WANG K, QIN XZ, RAN TJ, et al. Causal link between gut microbiota and four types of pancreatitis: a genetic association and bidirectional Mendelian randomization study[J]. Front Microbiol, 2023, 14: 1290202.

LI KK, ZHUO C, TENG CY, et al. Effects of Ganoderma lucidum polysaccharides on chronic pancreatitis and intestinal microbiota in mice[J]. Int J Biol Macromol, 2016, 93(Pt A): 904-912.

ILJAZOVIC A, ROY U, GÁLVEZ EJC, et al. Perturbation of the gut microbiome by Prevotella spp. enhances host susceptibility to mucosal inflammation[J]. Mucosal Immunol, 2021, 14(1): 113-124.

KARTAL E, SCHMIDT TSB, MOLINA-MONTES E, et al. A faecal microbiota signature with high specificity for pancreatic cancer[J]. Gut, 2022, 71(7): 1359-1372.

LEE YC, CHIANG TH, CHOU CK, et al. Association between Helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta-analysis[J]. Gastroenterology, 2016, 150(5): 1113-1124.e5.

RIEDER G, KARNHOLZ A, STOECKELHUBER M, et al. H pylori infection causes chronic pancreatitis in Mongolian gerbils[J]. World J Gastroenterol, 2007, 13(29): 3939-3947.

AI FL, HUA XD, LIU YF, et al. Preliminary study of pancreatic cancer associated with Helicobacter pylori infection[J]. Cell Biochem Biophys, 2015, 71(1): 397-400.

FREEDMAN HH. Further studies on passive transfer of tolerance to pyrogenicity of bacterial endotoxin. The febrile and leucopenic responses[J]. J Exp Med, 1960, 112(4): 619-634.

吴镭，贾彩，徐岩英，等. “非可控性炎症恶性转化的调控网络及其分子机制”重大研究计划结题综述[J]. 中国科学基金，2021, 35(2): 258-264.

侯圣忠，龙海若，田伯乐. 慢性胰腺炎时胰腺内、外分泌功能不全的发生机制及处理[J]. 中国普外基础与临床杂志，2018, 25(12): 1521-1526.

MITTAL M, SIDDIQUI MR, TRAN K, et al. Reactive oxygen species in inflammation and tissue injury[J]. Antioxid Redox Signal, 2014, 20(7): 1126-1167.

SRINIVAS US, TAN BWQ, VELLAYAPPAN BA, et al. ROS and the DNA damage response in cancer[J]. Redox Biol, 2019, 25: 101084.

MARSTRAND-DAUCÉ L, LORENZO D, CHASSAC A, et al. Acinar-to-ductal Metaplasia (ADM): on the road to pancreatic intraepithelial neoplasia (PanIN) and pancreatic cancer[J]. Int J Mol Sci, 2023, 24(12): 9946.

CARPENTER ES, ELHOSSINY AM, KADIYALA P, et al. Analysis of donor pancreata defines the transcriptomic signature and microenvironment of early neoplastic lesions[J]. Cancer Discov, 2023, 13(6): 1324-1345.

欧苏文，孙备，李乐. 瘤内微生物与胰腺癌的治疗[J]. 中华胰腺病杂志，2023, 23(5): 325-329.

XIANG H, TAO XF, XIA SL, et al. Emodin alleviates sodium taurocholate-induced pancreatic acinar cell injury via microRNA-30a-5p-mediated inhibition of high-temperature requirement A/transforming growth factor beta 1 inflammatory signaling[J]. Front Immunol, 2017, 8: 1488.

GUO FY, TAO XF, WU Y, et al. Carfilzomib relieves pancreatitis-initiated pancreatic ductal adenocarcinoma by inhibiting high-temperature requirement protein A1[J]. Cell Death Discov, 2024, 10(1): 58.

ZHANG GX, ZHAO XM, CAI J, et al. XCHT alleviates the pancreatic fibrosis via VDR/NLRP3 signaling pathway in a mouse model of CP[J]. J Ethnopharmacol, 2023, 300: 115689.

ZHANG SK, CUI NQ, ZHUO YZ, et al. Modified Xiaochaihu Decoction prevents the progression of chronic pancreatitis in rats possibly by inhibiting transforming growth factor-β1/Sma- and mad-related proteins signaling pathway[J]. Chin J Integr Med, 2013, 19(12): 935-939.

ZHANG SK, CUI NQ, ZHUO YZ, et al. Modified xiaochaihu decoction promotes collagen degradation and inhibits pancreatic fibrosis in chronic pancreatitis rats[J]. Chin J Integr Med, 2020, 26(8): 599-603.

DUAN LF, XU XF, ZHU LJ, et al. Dachaihu decoction ameliorates pancreatic fibrosis by inhibiting macrophage infiltration in chronic pancreatitis[J]. World J Gastroenterol, 2017, 23(40): 7242-7252.

CUI LH, LI CX, SHANG Y, et al. Chaihu Guizhi Ganjiang Decoction ameliorates pancreatic fibrosis via JNK/mTOR signaling pathway[J]. Front Pharmacol, 2021, 12: 679557.

ZENG XP, ZENG JH, LIN X, et al. Puerarin ameliorates caerulein-induced chronic pancreatitis via inhibition of MAPK signaling pathway[J]. Front Pharmacol, 2021, 12: 686992.

SUZUKI N, MASAMUNE A, KIKUTA K, et al. Ellagic acid inhibits pancreatic fibrosis in male Wistar Bonn/Kobori rats[J]. Dig Dis Sci, 2009, 54(4): 802-810.

TSANG SW, ZHANG H, LIN C, et al. Rhein, a natural anthraquinone derivative, attenuates the activation of pancreatic stellate cells and ameliorates pancreatic fibrosis in mice with experimental chronic pancreatitis[J]. PLoS One, 2013, 8(12): e82201.

TAO XF, CHEN Q, LI N, et al. Serotonin-RhoA/ROCK axis promotes acinar-to-ductal metaplasia in caerulein-induced chronic pancreatitis[J]. Biomed Pharmacother, 2020, 125: 109999.

PU WL, LUO YY, BAI RY, et al. Baicalein inhibits acinar-to-ductal metaplasia of pancreatic acinal cell AR42J via improving the inflammatory microenvironment[J]. J Cell Physiol, 2018, 233(8): 5747-5755.

QIAN WK, XIAO QG, WANG L, et al. Resveratrol slows the tumourigenesis of pancreatic cancer by inhibiting NFκB activation[J]. Biomed Pharmacother, 2020, 127: 110116.

BAI H, LI HN, ZHANG WY, et al. Inhibition of chronic pancreatitis and pancreatic intraepithelial neoplasia (PanIN) by capsaicin in LSL-KrasG12D/Pdx1-Cre mice[J]. Carcinogenesis, 2011, 32(11): 1689-1696.

LIU MM, YANG YJ, KANG WL, et al. Berberine inhibits pancreatic intraepithelial neoplasia by inhibiting glycolysis via the adenosine monophosphate-activated protein kinase pathway[J]. Eur J Pharmacol, 2022, 915: 174680.

TAO XF, XIANG H, PAN Y, et al. Pancreatitis initiated pancreatic ductal adenocarcinoma: pathophysiology explaining clinical evidence[J]. Pharmacol Res, 2021, 168: 105595.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

原发性多发肺结节“炎癌转化”机制探讨

王永炎教授基于“心主神明”理论论治心血管疾病

从“虚毒”探讨炎症性肠病“炎癌转化”

复方苁蓉益智胶囊治疗轻中度阿尔茨海默病患者的临床疗效研究

450例糖耐量减低患者中医体质分布及相关影响因素